Therapy Areas: Cardiovascular
Almirall names new chief executive officer
31 August 2017 -

Spain-based Almirall has named Peter Guenter as its new chief executive officer, it was reported yesterday.

The new chief executive officer is to succeed Eduardo Sanchiz, who leaves to dedicate more time to other interests.

Guenter joins from Sanofi, where he has worked for the past 22 years, most recently as executive vice president diabetes and cardiovascular global business unit. He earlier held various senior positions at Sanofi, including vice president Eastern Europe and Northern Europe, vice president business management and support, general manager, Germany, and senior vice president, Europe.

Sanchiz will hand over the Almirall leadership to Guenter during September.



Related Headlines